High Frequency of TP53 but not K-ras Gene Mutations in Bolivian Patients with Gallbladder Cancer |
Asai, Takao
(Department of Clinical Engineering and Medical Technology, Niigata University of Health and Welfare)
Loza, Ernesto (Bolivian Japanese Institute of Gastroenterology) Roig, Guido Villa-Gomez (Bolivian Japanese Institute of Gastroenterology) Ajioka, Yoichi (Division of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences) Tsuchiya, Yasuo (Department of Clinical Engineering and Medical Technology, Niigata University of Health and Welfare) Yamamoto, Masaharu (Department of Health Nutrition, Niigata University of Health and Welfare) Nakamura, Kazutoshi (Division of Preventive Medicine, Niigata University Graduate School of Medical and Dental Sciences) |
1 | Serra I, Yamamoto M, Calvo A, et al (2002). Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population. Int J Cancer, 102, 407-11. DOI ScienceOn |
2 | Srivastava V, Patel B, Kumar M, Shukla M, Pandey M (2013). Cyclin D1, retinoblastoma and p16 protein expression in carcinoma of the gallbladder. Asian Pac J Cancer Prev, 14, 2711-5. 과학기술학회마을 DOI ScienceOn |
3 | Takagi S, Naito E, Yamanouchi H, et al (1994). Mutation of the p53 gene in gallbladder cancer. Tohoku J Exp Med, 172, 283-9. DOI |
4 | Taner CB, Nagorney DM, Donohue JH (2004). Surgical treatment of gallbladder cancer. J Gastrointest Surg, 8, 83-9. DOI ScienceOn |
5 | Tsuchiya Y, Terao M, Okano K, et al (2011). Mutagenicity and mutagens of the red chili pepper as gallbladder cancer risk factor in Chilean women. Asian Pac J Cancer Prev, 12, 471-6. |
6 | Wu Q, He XD, Yu L, Liu W, Tao LY (2012). The metabolic syndrome and risk factors for biliary tract cancer: a case-control study in China. Asian Pac J Cancer Prev, 13, 1963-9. 과학기술학회마을 DOI ScienceOn |
7 | Yokoyama N, Hitomi J, Watanabe H, et al (1998a). Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile. Cancer Epidemiol Biomarkers Prev, 7, 297-301. |
8 | Yokoyama N, Watanabe H, Ajioka Y, et al (1998b). Genetic alterations in gallbladder carcinoma: a review. Nihon Geka Gakkai Zasshi, 99, 687-95. |
9 | Moore SP, Forman D, Pineros M, et al (2014). Cancer in indigenous people in Latin America and the Caribbean: a review. Cancer Med, 3, 70-80. DOI |
10 | Lazcano-Ponce EC, Miquel JF, Munoz N, et al (2001). Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin, 51, 349-64. DOI ScienceOn |
11 | Matsubara T, Sakurai Y, Sasayama Y, et al (1996). K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction. Cancer, 77, 1752-7. DOI |
12 | Misra S, Chaturvedi A, Misra NC, Sharma ID (2003). Carcinoma of the gallbladder. Lancet Oncol, 4, 167-76. DOI ScienceOn |
13 | Moreno M, Pimentel F, Gazdar AF, Wistuba Ii, Miquel JF (2005). TP53 abnormalities are frequent and early events in the sequential pathogenesis of gallbladder carcinoma. Ann Hepatol, 4, 192-9. |
14 | Nagahashi M, Ajioka Y, Lang I, et al (2008). Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary. World J Gastroenterol, 14, 70-5. DOI |
15 | Guo RS, Shi PD, Zhou J, Chen YY (2013). Somatostatin receptors 3, 4 and 5 play important roles in gallbladder cancer. Asian Pac J Cancer Prev, 14, 4071-5. 과학기술학회마을 DOI ScienceOn |
16 | Ozturk M (1991). p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet, 338, 1356-9. DOI ScienceOn |
17 | Randi G, Franceschi S, La Vecchia C (2006). Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer, 118, 1591-602. DOI ScienceOn |
18 | Rideout WM, 3rd, Coetzee GA, Olumi AF, Jones PA (1990). 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science, 249, 1288-90. DOI ScienceOn |
19 | Goldin RD, Roa JC (2009). Gallbladder cancer: a morphological and molecular update. Histopathology, 55, 218-29. DOI ScienceOn |
20 | Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res, 54, 4855-78. |
21 | Greene FL, Page DL, Fleming ID, et al (2002). American Joint Committee On Cancer Staging Manual, 6th edn (New York, Springer). |
22 | Hanada K, Itoh M, Fujii K, et al (1996). K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Cancer, 77, 452-8. DOI |
23 | Harris CC (1996). The 1995 Walter hubert lecture--molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene. Br J Cancer, 73, 261-9. DOI ScienceOn |
24 | Fujii K, Yokozaki H, Yasui W, et al (1996). High frequency of p53 gene mutation in adenocarcinomas of the gallbladder. Cancer Epidemiol Biomarkers Prev, 5, 461-6. |
25 | Hussain SP, Harris CC (2000). Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens. Mutat Res, 462, 311-22. DOI ScienceOn |
26 | Iwase T, Nakazawa S, Yamao K, et al (1997). Ras gene point mutations in gallbladder lesions associated with anomalous connection of pancreatobiliary ducts. Hepatogastroenterology, 44, 1457-62. |
27 | Jones PA, Buckley JD, Henderson BE, Ross RK, Pike MC (1991). From gene to carcinogen: a rapidly evolving field in molecular epidemiology. Cancer Res, 51, 3617-20. |
28 | Asai T, Tsuchiya Y, Okano K, et al (2012). Aflatoxin contamination of red chili pepper from Bolivia and Peru, countries with high gallbladder cancer incidence rates. Asian Pac J Cancer Prev, 13, 5167-70. 과학기술학회마을 DOI ScienceOn |
29 | Carriaga MT, Henson DE (1995). Liver, gallbladder, extrahepatic bile ducts and pancreas. Cancer, 75, 171-90. DOI |
30 | Chhabra D, Oda K, Jagannath P, et al (2012). Chronic heavy metal exposure and gallbladder cancer risk in India, a comparative study with Japan. Asian Pac J Cancer Prev, 13, 187-90. 과학기술학회마을 DOI ScienceOn |
31 | Funabiki T, Matsubara T, Miyakawa S, Ishihara S (2009). Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy. Langenbecks Arch Surg, 394, 159-69. DOI ScienceOn |
32 | Hanada K, Tsuchida A, Iwao T, et al (1999). Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Am J Gastroenterol, 94, 1638-42. DOI ScienceOn |
33 | Rai R, Tewari M, Kumar M, Singh AK, Shukla HS (2011). p53: its alteration and gallbladder cancer. Eur J Cancer Prev, 20, 77-85. DOI ScienceOn |
34 | Wistuba Ii, Gazdar AF (2004). Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer, 4, 695-706. DOI ScienceOn |
![]() |